Editorial: Product familiarisation programs Article Swipe
Greg Kyle
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.18773/austprescr.2017.076
· OA: W2775223879
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.18773/austprescr.2017.076
· OA: W2775223879
Product familiarisation programs (sometimes also called ‘patient familiarisation programs’) are provided by pharmaceutical companies and are designed to familiarise prescribers with a newly approved medicine while Pharmaceutical Benefits Scheme (PBS) listing is pending.1 They are usually targeted at specialists and, according to Medicine Australia’s Code of Conduct, each individual prescriber can only enrol up to ten patients in a program. The enrolment period is limited to six months, however extensions are allowed if there is a strong clinical or equity rationale.
Related Topics
Finding more related topics…